Tuberculosis in Spain: An opinion paper.

Intensive Care Unit Tuberculosis bedaquiline delamanid extrapulmonary tuberculosis incidence latent tuberculosis medical-legal aspects microbiological diagnosis new drugs pediatric tuberculosis populations at risk recurrence situation in Spain treatment vaccines

Journal

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
ISSN: 1988-9518
Titre abrégé: Rev Esp Quimioter
Pays: Spain
ID NLM: 9108821

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 29 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

This document is the result of the deliberations of the Committee on Emerging Pathogens and COVID-19 of the Illustrious Official College of Physicians of Madrid (ICOMEM) regarding the current situation of tuberculosis, particularly in Spain. We have reviewed aspects such as the evolution of its incidence, the populations currently most exposed and the health care circuits for the care of these patients in Spain. We have also discussed latent tuberculosis, the reality of extrapulmonary disease in the XXI century and the means available in daily practice for the diagnosis of both latent and active forms. The contribution of molecular biology, which has changed the perspective of this disease, was another topic of discussion. The paper tries to put into perspective both the classical drugs and their resistance figures and the availability and indications of the new ones. In addition, the reality of direct observation in the administration of antituberculosis drugs has been discussed. All this revolution is making it possible to shorten the treatment time for tuberculosis, a subject that has also been reviewed. If everything is done well, the risk of relapse of tuberculosis is small but it exists. On the other hand, many special situations have been discussed in this paper, such as tuberculosis in pediatric age and tuberculosis as a cause for concern in surgery and intensive care. The status of the BCG vaccine and its present indications as well as the future of new vaccines to achieve the old dream of eradicating this disease have been discussed. Finally, the ethical and medicolegal implications of this disease are not a minor issue and our situation in this regard has been reviewed.

Identifiants

pubmed: 37922367
doi: 10.37201/req/115.2023
pmc: PMC10710671
pii:
doi:

Substances chimiques

Antitubercular Agents 0
BCG Vaccine 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

562-583

Informations de copyright

©The Author 2023. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Références

Medicine (Baltimore). 1984 Jan;63(1):25-55
pubmed: 6419006
J Clin Microbiol. 2019 May 24;57(6):
pubmed: 30944200
Arch Bronconeumol. 2001 Jan;37(1):35-42
pubmed: 11181228
Arch Intern Med. 1990 Sep;150(9):1913-6
pubmed: 2393321
Euro Surveill. 2023 Mar;28(12):
pubmed: 36951787
Arch Intern Med. 2002 Sep 9;162(16):1873-9
pubmed: 12196086
Diagnostics (Basel). 2022 Feb 10;12(2):
pubmed: 35204544
Int J Tuberc Lung Dis. 1999 Oct;3(10 Suppl 2):S231-79
pubmed: 10529902
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331043
N Engl J Med. 2022 Mar 10;386(10):911-922
pubmed: 35263517
Eur Respir J. 2013 Jul;42(1):5-8
pubmed: 23813308
Thorax. 2023 Mar;78(3):288-296
pubmed: 36283826
Eur Respir J. 2022 May 19;59(5):
pubmed: 35589114
Lancet Microbe. 2023 Jun;4(6):e379
pubmed: 37269864
JAMA. 2023 May 2;329(17):1495-1509
pubmed: 37129650
Arch Bronconeumol. 2022 Dec;58(12):809-820
pubmed: 35945071
BMC Pulm Med. 2022 Oct 5;22(1):375
pubmed: 36199061
Acta Clin Belg. 2014 Oct;69(5):358-66
pubmed: 25018132
Scand J Infect Dis. 1999;31(4):387-91
pubmed: 10528879
Transplantation. 1997 May 15;63(9):1278-86
pubmed: 9158022
N Engl J Med. 2021 May 6;384(18):1705-1718
pubmed: 33951360
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
Immunity. 1995 Jun;2(6):561-72
pubmed: 7540941
Int J Tuberc Lung Dis. 2014 Apr;18(4):492-8
pubmed: 24670708
Clin Infect Dis. 1995 Aug;21(2):398-402
pubmed: 8562750
An Pediatr (Barc). 2016 Dec;85(6):323.e1-323.e11
pubmed: 27503786
Vaccine. 2021 Dec 8;39(50):7277-7285
pubmed: 34238608
N Engl J Med. 2018 Aug 2;379(5):454-463
pubmed: 30067928
Eur Respir J. 2004 Dec;24(6):895-6
pubmed: 15572527
Medicine (Baltimore). 1999 Sep;78(5):309-20
pubmed: 10499072
PLoS One. 2014 Mar 24;9(3):e92623
pubmed: 24663327
Infect Dis (Lond). 2017 Mar;49(3):161-169
pubmed: 27911140
Clin Infect Dis. 2007 Sep 15;45(6):715-22
pubmed: 17712755
Pediatr Infect Dis J. 2015 Sep;34(9):1014-9
pubmed: 26107342
Medicine (Baltimore). 1991 Nov;70(6):384-97
pubmed: 1956280
BMJ. 2014 Aug 05;349:g4643
pubmed: 25097193
Chest. 1991 Sep;100(3):678-81
pubmed: 1889256
Clin Infect Dis. 2008 Jul 1;47(1):8-14
pubmed: 18484876
Lung. 2016 Jun;194(3):447-58
pubmed: 27039307
MMWR Suppl. 1987 Aug 14;36(1):1S-15S
pubmed: 3039334
Front Pediatr. 2021 Apr 23;9:583197
pubmed: 33968839
Thorax. 2009 Dec;64(12):1090-5
pubmed: 19850965
Indian J Crit Care Med. 2021 May;25(Suppl 2):S150-S154
pubmed: 34345130
Lancet Infect Dis. 2022 Jan;22(1):e2-e12
pubmed: 34506734
Chest. 2013 Aug;144(2):474-482
pubmed: 23429859
Rev Clin Esp. 1983 Oct 31;171(2):89-92
pubmed: 6658099
Thorax. 2021 May;76(5):494-502
pubmed: 33547088
PLoS Med. 2019 Oct 31;16(10):e1002961
pubmed: 31671150
PLoS One. 2022 Jun 16;17(6):e0268290
pubmed: 35709199
J Crit Care. 2018 Jun;45:184-196
pubmed: 29571116
Am Rev Respir Dis. 1973 Oct;108(4):799-804
pubmed: 4741874
Rev Esp Quimioter. 2022 Oct;35 Suppl 3:94-96
pubmed: 36285867
Lancet Microbe. 2023 Jan;4(1):e20
pubmed: 36521512
An Pediatr (Engl Ed). 2023 Jun;98(6):460-469
pubmed: 37236883
Thorax. 2022 Oct;77(10):1023-1029
pubmed: 36357344
Science. 2005 Jan 14;307(5707):223-7
pubmed: 15591164
Lancet Infect Dis. 2019 Feb;19(2):193-202
pubmed: 30655049
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):785-8
pubmed: 3145865
Front Med (Lausanne). 2021 Sep 14;8:685368
pubmed: 34595184
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Mar;36(3):179-186
pubmed: 29326000
Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):514-521
pubmed: 32446667
Clin Infect Dis. 2016 Oct 1;63(7):853-67
pubmed: 27621353
Clin Infect Dis. 2016 Apr 1;62(7):887-895
pubmed: 26757804
Pediatrics. 1997 Feb;99(2):226-31
pubmed: 9024451
J Clin Med. 2022 Sep 30;11(19):
pubmed: 36233689
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33822988
Ann Intern Med. 2008 Aug 5;149(3):177-84
pubmed: 18593687
Arch Bronconeumol. 2009 Mar;45(3):139-44
pubmed: 19251347
Lancet Glob Health. 2022 Sep;10(9):e1307-e1316
pubmed: 35961354
Enferm Infecc Microbiol Clin. 2016 May;34(5):303.e1-13
pubmed: 26917222
Ann Acad Med Singap. 2002 Mar;31(2):175-81
pubmed: 11957554
Pediatrics. 2020 Jan;145(1):
pubmed: 31892518
Indian J Med Res. 2004 Oct;120(4):316-53
pubmed: 15520485
N Engl J Med. 1946 Aug 22;235:239-48
pubmed: 20996257
Rev Urol. 2008 Summer;10(3):207-17
pubmed: 18836557
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195
pubmed: 27516382
Clin Infect Dis. 2023 Jun 8;76(11):1989-1999
pubmed: 36688489
Am Rev Respir Dis. 1989 Dec;140(6):1788-95
pubmed: 2604302
N Engl J Med. 2019 Mar 28;380(13):1201-1213
pubmed: 30865791
Bull Int Union Tuberc. 1978 Jun;53(2):70-5
pubmed: 737353
Br J Surg. 1990 Aug;77(8):911-2
pubmed: 2118407
Int J Tuberc Lung Dis. 2005 Feb;9(2):188-94
pubmed: 15732739
Am Rev Respir Dis. 1989 Apr;139(4):867-70
pubmed: 2930066
N Engl J Med. 2008 Aug 7;359(6):563-74
pubmed: 18687637
Enferm Infecc Microbiol Clin (Engl Ed). 2018 May;36(5):302-311
pubmed: 29295754
Ann Rheum Dis. 2010 Mar;69(3):522-8
pubmed: 19854715
Pediatr Infect Dis J. 2018 Jul;37(7):637-642
pubmed: 29278611
Respir Care. 2018 Dec;63(12):1541-1554
pubmed: 30206126
MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):285-289
pubmed: 35202353
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005159
pubmed: 17943842
Med Clin (Barc). 2021 Apr 23;156(8):393-401
pubmed: 33531151
Arch Bronconeumol. 2010 May;46(5):255-74
pubmed: 20444533
N Engl J Med. 2018 Aug 30;379(9):823-833
pubmed: 30157391
Eur Respir J. 2015 Dec;46(6):1563-76
pubmed: 26405286
Am Rev Respir Dis. 1989 Apr;139(4):871-6
pubmed: 2648911
Clin Infect Dis. 2015 Jun 1;60(11):1611-9
pubmed: 25725054
Int J Tuberc Lung Dis. 2022 Dec 1;26(12):1183-1185
pubmed: 36447313
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):557-64
pubmed: 23058005
Pulmonology. 2022 Jul-Aug;28(4):297-309
pubmed: 35227650
N Engl J Med. 2001 Oct 11;345(15):1098-104
pubmed: 11596589
Lancet Microbe. 2020 Aug;1(4):e175-e183
pubmed: 35544271
Int J Infect Dis. 2022 Mar;116:14-20
pubmed: 34954094
PLoS One. 2021 Feb 19;16(2):e0247411
pubmed: 33606824
Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52
pubmed: 19783328
PLoS One. 2012;7(11):e50155
pubmed: 23226243
Pediatr Radiol. 2017 Sep;47(10):1260-1268
pubmed: 29052772
Trop Med Int Health. 2021 Jan;26(1):111-114
pubmed: 33159399
Lancet Respir Med. 2015 Jun;3(6):451-61
pubmed: 25812968
Clin Infect Dis. 2014 Jun;58(12):1676-83
pubmed: 24647020
Sci Rep. 2020 Feb 17;10(1):2704
pubmed: 32066749
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Singapore Med J. 2017 Nov;58(11):656-659
pubmed: 27653545
Medicine (Baltimore). 2002 May;81(3):179-93
pubmed: 11997715
Eur Respir J. 2009 Jul;34(1):180-3
pubmed: 19567603
Clin Infect Dis. 2009 Nov 1;49(9):1350-7
pubmed: 19793000
Infection. 2022 Jun;50(3):597-606
pubmed: 35249210
N Engl J Med. 1994 Apr 28;330(17):1179-84
pubmed: 8139628
Pediatr Infect Dis J. 1991 Mar;10(3):179-83
pubmed: 2041662
Gac Sanit. 2016 Mar-Apr;30(2):144-7
pubmed: 26832855
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11
pubmed: 32053584
Front Microbiol. 2022 May 31;13:924410
pubmed: 35711765
Microb Drug Resist. 2018 Jul/Aug;24(6):839-843
pubmed: 29608388
Lancet Infect Dis. 2008 Aug;8(8):498-510
pubmed: 18652996
PLoS One. 2011 Jan 20;6(1):e16272
pubmed: 21283716
Lancet Microbe. 2023 Feb;4(2):e84-e92
pubmed: 36549315
Tuberculosis (Edinb). 2021 Jan;126:102022
pubmed: 33341027
Eur Respir J. 2017 Jul 27;50(1):
pubmed: 28751411
Cochrane Database Syst Rev. 2016 Apr 28;4:CD002244
pubmed: 27121755

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH